Justin F. Gainor

Oncology
10 Grove St
Boston, MA 02114

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 252 publications

Small Cell Lung Cancer Transformation in Actionable Genomic Alteration-Negative Non-Small Cell Lung Cancer With Response to Tarlatamab: A Case Report.

Small Cell Lung Cancer Transformation in Actionable Genomic Alteration-Negative Non-Small Cell Lung Cancer With Response to Tarlatamab: A Case Report.

Journal: JCO precision oncology
Published: September 04, 2026

Regulatory Perspectives in Precision Oncology: Challenges and Opportunities for Tyrosine Receptor Kinase (NTRK) Inhibitors in Non-small Cell Lung Cancer (NSCLC).

Regulatory Perspectives in Precision Oncology: Challenges and Opportunities for Tyrosine Receptor Kinase (NTRK) Inhibitors in Non-small Cell Lung Cancer (NSCLC).

Journal: Cureus
Published: July 13, 2026

Navigating NTRK in Non-small Cell Lung Cancer (NSCLC): A Patient Perspective.

Navigating NTRK in Non-small Cell Lung Cancer (NSCLC): A Patient Perspective.

Journal: Cureus
Published: June 23, 2026

Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced RET Fusion-Positive Non-Small Cell Lung Cancer.

Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced RET Fusion-Positive Non-Small Cell Lung Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 26, 2026

Recalibrating Dual Checkpoint Blockade? Lessons from Volrustomig.

Recalibrating Dual Checkpoint Blockade? Lessons from Volrustomig.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 13, 2026

Real-world multi-institution analysis of tarlatamab in patients with small cell lung cancer.

Real-world multi-institution analysis of tarlatamab in patients with small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 23, 2025

Combination therapy with lorlatinib and mitogen-activated protein kinase pathway inhibition in previously treated ALK- or ROS1-rearranged lung cancer.

Combination therapy with lorlatinib and mitogen-activated protein kinase pathway inhibition in previously treated ALK- or ROS1-rearranged lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 09, 2025

TTF-1 Expression in Lung Adenocarcinoma: Clinicopathologic, Genomic, and Immunophenotypic Correlates and Outcomes to Immunotherapy-Based Treatments and KRASG12C Inhibitors.

TTF-1 Expression in Lung Adenocarcinoma: Clinicopathologic, Genomic, and Immunophenotypic Correlates and Outcomes to Immunotherapy-Based Treatments and KRASG12C Inhibitors.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 21, 2025

Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium.

Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 17, 2025

Global advances and future directions in lung cancer care: expert consensus and strategic priorities.

Global advances and future directions in lung cancer care: expert consensus and strategic priorities.

Journal: ESMO open
Published: November 15, 2025

Neighborhood Socioeconomics and Lung Cancer Recurrence and Progression.

Neighborhood Socioeconomics and Lung Cancer Recurrence and Progression.

Journal: Clinical lung cancer
Published: November 10, 2025

Aging dictates tumor-specific genomic alterations across cancer types.

Aging dictates tumor-specific genomic alterations across cancer types.

Journal: npj aging
Published: October 16, 2025
Showing 1-12 of 252

Last Updated: 09/26/2026